Status:
COMPLETED
Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
Lead Sponsor:
University of California, San Francisco
Conditions:
Opioid; Intoxication, Perception Disturbance (Acute)
Acute Pain
Eligibility:
All Genders
20-55 years
Phase:
PHASE1
Brief Summary
Volunteers will receive a weight-based opioid (remifentanil) infusion for 10 minutes. In the first run, serial pupillary measurements (pupillary unrest, pupil diameter) will be taken at baseline, and ...
Detailed Description
Healthy volunteers aged 20-55 will receive a weight-based opioid (remifentanil) infusion for 10 minutes. Vital signs including SpO2, transcutaneous CO2, and respiratory rate will be continuously measu...
Eligibility Criteria
Inclusion
- Healthy
- Able to provide informed consent
Exclusion
- Active substance use disorder
- Prior opioid use disorder
- Opioid use within 30 days.
Key Trial Info
Start Date :
April 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04301895
Start Date
April 30 2019
End Date
September 3 2019
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143